Exagen Inc. XGN Cost Of Goods And Services Sold Depreciation And Amortization
Cost Of Goods And Services Sold Depreciation And Amortization at other companies
Other financials
Where this comes from
Reported directly by Exagen Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization.
The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s cost of goods and services sold depreciation and amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exagen Inc.'s cost of goods and services sold depreciation and amortization?
- Exagen Inc. (XGN) reported cost of goods and services sold depreciation and amortization of $599K in Q1 2026.
- How has Exagen Inc.'s cost of goods and services sold depreciation and amortization changed year-over-year?
- Exagen Inc.'s cost of goods and services sold depreciation and amortization increased by 36.1% year-over-year, from $440K to $599K.
- What is the long-term trend for Exagen Inc.'s cost of goods and services sold depreciation and amortization?
- Over 4 years (2021 to 2025), Exagen Inc.'s cost of goods and services sold depreciation and amortization has grown at a 22.3% compound annual growth rate (CAGR), from $948K to $2.12M.
- What does cost of goods and services sold depreciation and amortization mean?
- This metric represents the portion of depreciation and amortization expenses directly attributable to the production of goods or the delivery of diagnostic services. It reflects the non-cash cost of utilizing tangible and intangible assets in the core operational revenue-generating process. Monitoring this helps investors understand the capital intensity of the company's diagnostic testing operations.